Natco Pharma Aims for Majority Stake in Adcock Holdings, South Africa
Ahead of a crucial board meeting today, Adcock Holdings’ shares experienced a surge of 10%, following the announcement that discussions regarding a potential deal are underway.
Adcock Ingram, which operates under the Adcock Holdings umbrella, offers a broad range of generic and over-the-counter medications throughout Africa. The company currently has three manufacturing facilities in South Africa and operates two additional ones in India through a joint venture.
At present, Adcock’s stock is trading at a price-to-earnings ratio of 10 and boasts a market capitalization of around ₹4,500 crore.
While CNBC Awaaz has reached out to Natco Pharma for comment, there has yet to be any official response.
As of Wednesday, shares of Natco Pharma Ltd. have shown a slight uptick, trading 0.52% higher at ₹1,019.95.
Are you interested in how this potential acquisition might impact the pharmaceutical industry?
Introduction A significant development in global connectivity is underway, as a new cable system aims to link India, the Middle Read more
Expansion Plans for Bharti Airtel in Africa Bharti Airtel is reportedly eyeing a potential acquisition of a smaller telecommunications operator Read more
Seacom's Major Submarine Cable Network Upgrade Seacom is embarking on a significant enhancement of its submarine cable network along the Read more
## Jolla's Expansion into the African Market Jolla has recently unveiled plans to establish a Sailfish OS ecosystem in Africa, Read more